Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S25 pseudogenes are non-functional genomic sequences that are similar in sequence to the functional ribosomal protein S25 (RPS25) gene but do not encode an active protein product[2][9]. The RPS25 gene encodes a component of the small 40S ribosomal subunit essential for protein synthesis. However, its associated pseudogenes, such as ENSG00000185641, arise from duplication events and do not produce functional ribosomal proteins[9]. These pseudogenes do not serve as therapeutic targets and have no known biological or disease-related functions, and thus are not relevant for drug development or patient stratification[2][9][12]. ENSG00000185641 refers to a ribosomal protein S25 pseudogene; as a non-coding genomic remnant, it is not considered a therapeutic target, lacks molecular function, and is not involved in disease or drug response. Any reference to this as a target is incorrect or misleading[2][9][12].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S25 pseudogene (None).